Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 145 to 155 of 155 entries
Sorted by: Best Match Show Resources per page
Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery.

Journal of pediatric orthopedics

Beber SA, Sanborn RM, Miller PE, Kasser JR, Waters PM, Watkins CJ, Shore BJ.
PMID: 34545019
J Pediatr Orthop. 2022 Jan 01;42(1):e39-e44. doi: 10.1097/BPO.0000000000001977.

BACKGROUND: Adult literature has demonstrated chlorhexidine (CH) superiority at preventing surgical-site infections when compared with povidone-iodine (P-I). The purpose of this study is to compare the rate of postoperative infections after preoperative skin cleansing with either CH or P-I...

Cite
Beber SA, Sanborn RM, Miller PE, et al. Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery. J Pediatr Orthop. 2022;42(1):e39-e44doi: 10.1097/BPO.0000000000001977.
Beber, S. A., Sanborn, R. M., Miller, P. E., Kasser, J. R., Waters, P. M., Watkins, C. J., & Shore, B. J. (2022). Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery. Journal of pediatric orthopedics, 42(1), e39-e44. https://doi.org/10.1097/BPO.0000000000001977
Beber, Samuel A, et al. "Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery." Journal of pediatric orthopedics vol. 42,1 (2022): e39-e44. doi: https://doi.org/10.1097/BPO.0000000000001977
Beber SA, Sanborn RM, Miller PE, Kasser JR, Waters PM, Watkins CJ, Shore BJ. Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery. J Pediatr Orthop. 2022 Jan 01;42(1):e39-e44. doi: 10.1097/BPO.0000000000001977. PMID: 34545019.
Copy Download .nbib Format: NLM
Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery.

Journal of pediatric orthopedics

Beber SA, Sanborn RM, Miller PE, Kasser JR, Waters PM, Watkins CJ, Shore BJ.
PMID: 34545019
J Pediatr Orthop. 2022 Jan 01;42(1):e39-e44. doi: 10.1097/BPO.0000000000001977.

BACKGROUND: Adult literature has demonstrated chlorhexidine (CH) superiority at preventing surgical-site infections when compared with povidone-iodine (P-I). The purpose of this study is to compare the rate of postoperative infections after preoperative skin cleansing with either CH or P-I...

Cite
Beber SA, Sanborn RM, Miller PE, et al. Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery. J Pediatr Orthop. 2022;42(1):e39-e44doi: 10.1097/BPO.0000000000001977.
Beber, S. A., Sanborn, R. M., Miller, P. E., Kasser, J. R., Waters, P. M., Watkins, C. J., & Shore, B. J. (2022). Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery. Journal of pediatric orthopedics, 42(1), e39-e44. https://doi.org/10.1097/BPO.0000000000001977
Beber, Samuel A, et al. "Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery." Journal of pediatric orthopedics vol. 42,1 (2022): e39-e44. doi: https://doi.org/10.1097/BPO.0000000000001977
Beber SA, Sanborn RM, Miller PE, Kasser JR, Waters PM, Watkins CJ, Shore BJ. Jumping on the Bandwagon: Comparing the Efficacy of Chlorhexidine Versus Povidone-Iodine Preoperative Skin Antiseptic in Preventing Surgical Site Infections Following Pediatric Orthopaedic Surgery. J Pediatr Orthop. 2022 Jan 01;42(1):e39-e44. doi: 10.1097/BPO.0000000000001977. PMID: 34545019.
Copy Download .nbib Format: NLM
Scope and limitations of a multiplex conventional PCR for the diagnosis of S. stercoralis and hookworms.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases

Fleitas PE, Vargas PA, Caro N, Almazan MC, Echazú A, Juárez M, Cajal P, Krolewiecki AJ, Nasser JR, Cimino RO.
PMID: 34774469
Braz J Infect Dis. 2021 Nov-Dec;25(6):101649. doi: 10.1016/j.bjid.2021.101649. Epub 2021 Nov 10.

OBJECTIVES: Describe the diagnostic characteristics of a conventional multiplex PCR for the diagnosis of S. stercoralis, N. americanus and Ancylostomas spp.METHODS: Fecal samples were collected from a cross-sectional study in Orán department, Salta province, Argentina. The stool samples were...

Cite
Fleitas PE, Vargas PA, Caro N, et al. Scope and limitations of a multiplex conventional PCR for the diagnosis of S. stercoralis and hookworms. Braz J Infect Dis. 2021;25(6):101649doi: 10.1016/j.bjid.2021.101649.
Fleitas, P. E., Vargas, P. A., Caro, N., Almazan, M. C., Echazú, A., Juárez, M., Cajal, P., Krolewiecki, A. J., Nasser, J. R., & Cimino, R. O. (2021). Scope and limitations of a multiplex conventional PCR for the diagnosis of S. stercoralis and hookworms. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 25(6), 101649. https://doi.org/10.1016/j.bjid.2021.101649
Fleitas, Pedro E, et al. "Scope and limitations of a multiplex conventional PCR for the diagnosis of S. stercoralis and hookworms." The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases vol. 25,6 (2021): 101649. doi: https://doi.org/10.1016/j.bjid.2021.101649
Fleitas PE, Vargas PA, Caro N, Almazan MC, Echazú A, Juárez M, Cajal P, Krolewiecki AJ, Nasser JR, Cimino RO. Scope and limitations of a multiplex conventional PCR for the diagnosis of S. stercoralis and hookworms. Braz J Infect Dis. 2021 Nov-Dec;25(6):101649. doi: 10.1016/j.bjid.2021.101649. Epub 2021 Nov 10. PMID: 34774469.
Copy Download .nbib Format: NLM
Decreasing early hypoglycemia frequency in at-risk newborns after implementing a new hypoglycemia screening algorithm.

Journal of perinatology : official journal of the California Perinatal Association

Sivarajan M, Schneider JH, Johnson KA, Bai S, ElHassan NO, Kaiser JR, Nelson DB, Brown LS, Burchfield PJ, Brion LP.
PMID: 34789816
J Perinatol. 2021 Nov 17; doi: 10.1038/s41372-021-01263-8. Epub 2021 Nov 17.

BACKGROUND: Neonatal hypoglycemia may affect long-term neurodevelopment.METHODS: Quality improvement (QI) initiative for Mother-Baby-Unit (MBU) admissions (birthweight ≥ 2100 g; ≥35 weeks' gestation) over two epochs from 2016-2019 to reduce the frequency of early (≤3 h) neonatal hypoglycemia in small...

Cite
Sivarajan M, Schneider JH, Johnson KA, et al. Decreasing early hypoglycemia frequency in at-risk newborns after implementing a new hypoglycemia screening algorithm. J Perinatol. 2021;doi: 10.1038/s41372-021-01263-8.
Sivarajan, M., Schneider, J. H., Johnson, K. A., Bai, S., ElHassan, N. O., Kaiser, J. R., Nelson, D. B., Brown, L. S., Burchfield, P. J., & Brion, L. P. (2021). Decreasing early hypoglycemia frequency in at-risk newborns after implementing a new hypoglycemia screening algorithm. Journal of perinatology : official journal of the California Perinatal Association, . https://doi.org/10.1038/s41372-021-01263-8
Sivarajan, Muraleedharan, et al. "Decreasing early hypoglycemia frequency in at-risk newborns after implementing a new hypoglycemia screening algorithm." Journal of perinatology : official journal of the California Perinatal Association vol. (2021). doi: https://doi.org/10.1038/s41372-021-01263-8
Sivarajan M, Schneider JH, Johnson KA, Bai S, ElHassan NO, Kaiser JR, Nelson DB, Brown LS, Burchfield PJ, Brion LP. Decreasing early hypoglycemia frequency in at-risk newborns after implementing a new hypoglycemia screening algorithm. J Perinatol. 2021 Nov 17; doi: 10.1038/s41372-021-01263-8. Epub 2021 Nov 17. PMID: 34789816.
Copy Download .nbib Format: NLM
Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies.

Blood cancer discovery

Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL.
PMID: 34027417
Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.BCD-20-0105. Epub 2021 Mar 10.

Thalidomide analogs exert their therapeutic effects by binding to the CRL4

Cite
Renneville A, Gasser JA, Grinshpun DE, et al. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021;2(3):250-265doi: 10.1158/2643-3230.BCD-20-0105.
Renneville, A., Gasser, J. A., Grinshpun, D. E., Jean Beltran, P. M., Udeshi, N. D., Matyskiela, M. E., Clayton, T., McConkey, M., Viswanathan, K., Tepper, A., Guirguis, A. A., Sellar, R. S., Cotteret, S., Marzac, C., Saada, V., De Botton, S., Kiladjian, J. J., Cayuela, J. M., Rolfe, M., Chamberlain, P. P., Carr, S. A., & Ebert, B. L. (2021). Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood cancer discovery, 2(3), 250-265. https://doi.org/10.1158/2643-3230.BCD-20-0105
Renneville, Aline, et al. "Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies." Blood cancer discovery vol. 2,3 (2021): 250-265. doi: https://doi.org/10.1158/2643-3230.BCD-20-0105
Renneville A, Gasser JA, Grinshpun DE, Jean Beltran PM, Udeshi ND, Matyskiela ME, Clayton T, McConkey M, Viswanathan K, Tepper A, Guirguis AA, Sellar RS, Cotteret S, Marzac C, Saada V, De Botton S, Kiladjian JJ, Cayuela JM, Rolfe M, Chamberlain PP, Carr SA, Ebert BL. Avadomide induces degradation of ZMYM2 fusion oncoproteins in hematologic malignancies. Blood Cancer Discov. 2021 May;2(3):250-265. doi: 10.1158/2643-3230.BCD-20-0105. Epub 2021 Mar 10. PMID: 34027417; PMCID: PMC8133393.
Copy Download .nbib Format: NLM
3D Bioprinted Bacteriostatic Hyperelastic Bone Scaffold for Damage-Specific Bone Regeneration.

Polymers

Shokouhimehr M, Theus AS, Kamalakar A, Ning L, Cao C, Tomov ML, Kaiser JM, Goudy S, Willett NJ, Jang HW, LaRock CN, Hanna P, Lechtig A, Yousef M, Martins JDS, Nazarian A, Harris MB, Mahmoudi M, Serpooshan V.
PMID: 33808295
Polymers (Basel). 2021 Mar 30;13(7). doi: 10.3390/polym13071099.

Current strategies for regeneration of large bone fractures yield limited clinical success mainly due to poor integration and healing. Multidisciplinary approaches in design and development of functional tissue engineered scaffolds are required to overcome these translational challenges. Here, a...

Cite
Shokouhimehr M, Theus AS, Kamalakar A, et al. 3D Bioprinted Bacteriostatic Hyperelastic Bone Scaffold for Damage-Specific Bone Regeneration. Polymers (Basel). 2021;13(7)doi: 10.3390/polym13071099.
Shokouhimehr, M., Theus, A. S., Kamalakar, A., Ning, L., Cao, C., Tomov, M. L., Kaiser, J. M., Goudy, S., Willett, N. J., Jang, H. W., LaRock, C. N., Hanna, P., Lechtig, A., Yousef, M., Martins, J. D. S., Nazarian, A., Harris, M. B., Mahmoudi, M., & Serpooshan, V. (2021). 3D Bioprinted Bacteriostatic Hyperelastic Bone Scaffold for Damage-Specific Bone Regeneration. Polymers, 13(7), . https://doi.org/10.3390/polym13071099
Shokouhimehr, Mohammadreza, et al. "3D Bioprinted Bacteriostatic Hyperelastic Bone Scaffold for Damage-Specific Bone Regeneration." Polymers vol. 13,7 (2021). doi: https://doi.org/10.3390/polym13071099
Shokouhimehr M, Theus AS, Kamalakar A, Ning L, Cao C, Tomov ML, Kaiser JM, Goudy S, Willett NJ, Jang HW, LaRock CN, Hanna P, Lechtig A, Yousef M, Martins JDS, Nazarian A, Harris MB, Mahmoudi M, Serpooshan V. 3D Bioprinted Bacteriostatic Hyperelastic Bone Scaffold for Damage-Specific Bone Regeneration. Polymers (Basel). 2021 Mar 30;13(7). doi: 10.3390/polym13071099. PMID: 33808295; PMCID: PMC8036866.
Copy Download .nbib Format: NLM
Childhood Educational Outcomes of Children Born with Gastroschisis.

The Journal of pediatrics

ElHassan NO, Sharma M, Akmyradov C, Kaiser JR, Goudie A, Nembhard WN.
PMID: 34499945
J Pediatr. 2021 Sep 06; doi: 10.1016/j.jpeds.2021.08.086. Epub 2021 Sep 06.

OBJECTIVE: To compare third grade literacy and mathematics test proficiency among children born with gastroschisis vs unaffected controls and identify predictors of academic proficiency among these children.STUDY DESIGN: Infants born with gastroschisis (2000-2005) were identified from the Arkansas Reproductive...

Cite
ElHassan NO, Sharma M, Akmyradov C, et al. Childhood Educational Outcomes of Children Born with Gastroschisis. J Pediatr. 2021;doi: 10.1016/j.jpeds.2021.08.086.
ElHassan, N. O., Sharma, M., Akmyradov, C., Kaiser, J. R., Goudie, A., & Nembhard, W. N. (2021). Childhood Educational Outcomes of Children Born with Gastroschisis. The Journal of pediatrics, . https://doi.org/10.1016/j.jpeds.2021.08.086
ElHassan, Nahed O, et al. "Childhood Educational Outcomes of Children Born with Gastroschisis." The Journal of pediatrics vol. (2021). doi: https://doi.org/10.1016/j.jpeds.2021.08.086
ElHassan NO, Sharma M, Akmyradov C, Kaiser JR, Goudie A, Nembhard WN. Childhood Educational Outcomes of Children Born with Gastroschisis. J Pediatr. 2021 Sep 06; doi: 10.1016/j.jpeds.2021.08.086. Epub 2021 Sep 06. PMID: 34499945.
Copy Download .nbib Format: NLM
Pyrene Tags for the Detection of Carbohydrates by Label-Assisted Laser Desorption/Ionisation Mass Spectrometry*.

Chembiochem : a European journal of chemical biology

Hauser JR, Bergström ET, Kulak AN, Warriner SL, Thomas-Oates J, Bon RS.
PMID: 33296552
Chembiochem. 2021 Apr 16;22(8):1430-1439. doi: 10.1002/cbic.202000721. Epub 2021 Jan 04.

Matrix-assisted laser desorption/ionisation mass spectrometry (MALDI-MS) is widely used for the analysis of biomolecules. Label-assisted laser desorption/ionisation mass spectrometry (LALDI-MS) is a matrix-free variant of MALDI-MS, in which only analytes covalently attached to a laser desorption/ionisation (LDI) enhancer are...

Cite
Hauser JR, Bergström ET, Kulak AN, et al. Pyrene Tags for the Detection of Carbohydrates by Label-Assisted Laser Desorption/Ionisation Mass Spectrometry*. Chembiochem. 2021;22(8):1430-1439doi: 10.1002/cbic.202000721.
Hauser, J. R., Bergström, E. T., Kulak, A. N., Warriner, S. L., Thomas-Oates, J., & Bon, R. S. (2021). Pyrene Tags for the Detection of Carbohydrates by Label-Assisted Laser Desorption/Ionisation Mass Spectrometry*. Chembiochem : a European journal of chemical biology, 22(8), 1430-1439. https://doi.org/10.1002/cbic.202000721
Hauser, Jacob R, et al. "Pyrene Tags for the Detection of Carbohydrates by Label-Assisted Laser Desorption/Ionisation Mass Spectrometry*." Chembiochem : a European journal of chemical biology vol. 22,8 (2021): 1430-1439. doi: https://doi.org/10.1002/cbic.202000721
Hauser JR, Bergström ET, Kulak AN, Warriner SL, Thomas-Oates J, Bon RS. Pyrene Tags for the Detection of Carbohydrates by Label-Assisted Laser Desorption/Ionisation Mass Spectrometry*. Chembiochem. 2021 Apr 16;22(8):1430-1439. doi: 10.1002/cbic.202000721. Epub 2021 Jan 04. PMID: 33296552.
Copy Download .nbib Format: NLM
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Byrne KT, Betts CB, Mick R, Sivagnanam S, Bajor DL, Laheru DA, Chiorean EG, O'Hara MH, Liudahl SM, Newcomb C, Alanio C, Ferreira AP, Park BS, Ohtani T, Huffman AP, Väyrynen SA, Dias Costa A, Kaiser JC, Lacroix AM, Redlinger C, Stern M, Nowak JA, Wherry EJ, Cheever MA, Wolpin BM, Furth EE, Jaffee EM, Coussens LM, Vonderheide RH.
PMID: 34112709
Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10.

PURPOSE: CD40 activation is a novel clinical opportunity for cancer immunotherapy. Despite numerous active clinical trials with agonistic CD40 monoclonal antibodies (mAb), biological effects and treatment-related modulation of the tumor microenvironment (TME) remain poorly understood.PATIENTS AND METHODS: Here, we...

Cite
Byrne KT, Betts CB, Mick R, et al. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021;27(16):4574-4586doi: 10.1158/1078-0432.CCR-21-1047.
Byrne, K. T., Betts, C. B., Mick, R., Sivagnanam, S., Bajor, D. L., Laheru, D. A., Chiorean, E. G., O'Hara, M. H., Liudahl, S. M., Newcomb, C., Alanio, C., Ferreira, A. P., Park, B. S., Ohtani, T., Huffman, A. P., Väyrynen, S. A., Dias Costa, A., Kaiser, J. C., Lacroix, A. M., Redlinger, C., Stern, M., Nowak, J. A., Wherry, E. J., Cheever, M. A., Wolpin, B. M., Furth, E. E., Jaffee, E. M., Coussens, L. M., & Vonderheide, R. H. (2021). Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(16), 4574-4586. https://doi.org/10.1158/1078-0432.CCR-21-1047
Byrne, Katelyn T, et al. "Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,16 (2021): 4574-4586. doi: https://doi.org/10.1158/1078-0432.CCR-21-1047
Byrne KT, Betts CB, Mick R, Sivagnanam S, Bajor DL, Laheru DA, Chiorean EG, O'Hara MH, Liudahl SM, Newcomb C, Alanio C, Ferreira AP, Park BS, Ohtani T, Huffman AP, Väyrynen SA, Dias Costa A, Kaiser JC, Lacroix AM, Redlinger C, Stern M, Nowak JA, Wherry EJ, Cheever MA, Wolpin BM, Furth EE, Jaffee EM, Coussens LM, Vonderheide RH. Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer. Clin Cancer Res. 2021 Aug 15;27(16):4574-4586. doi: 10.1158/1078-0432.CCR-21-1047. Epub 2021 Jun 10. PMID: 34112709; PMCID: PMC8667686.
Copy Download .nbib Format: NLM
Presumed Fair: Ironic Effects of Organizational Diversity Structures.

Kaiser CR, Major B, Jurcevic I, Dover TL, Brady LM, Shapiro JR.
UIID-AD: 506
2013;104:504-519. doi: 10.1037/a0030838.

This research tests the hypothesis that the presence (vs. absence) of organizational diversity structures causes high-status group members (Whites, men) to perceive organizations with diversity structures as procedurally fairer environments for underrepresented groups (racial minorities, women), even when it...

Cite
Kaiser CR, Major B, Jurcevic I, et al. Presumed Fair: Ironic Effects of Organizational Diversity Structures. 2013;104:504-519doi: 10.1037/a0030838.
Kaiser, C. R., Major, B., Jurcevic, I., Dover, T. L., Brady, L. M., & Shapiro, J. R. (2013). Presumed Fair: Ironic Effects of Organizational Diversity Structures. 104504-519. https://doi.org/10.1037/a0030838
Kaiser, C R, et al. "Presumed Fair: Ironic Effects of Organizational Diversity Structures." vol. 104 (2013): 504-519. doi: https://doi.org/10.1037/a0030838
Kaiser CR, Major B, Jurcevic I, Dover TL, Brady LM, Shapiro JR. Presumed Fair: Ironic Effects of Organizational Diversity Structures. 2013;104:504-519. doi: 10.1037/a0030838. UIID-AD: 506.
Copy Download .nbib Format: NLM
Do women who succeed in male-dominated domains help other women? The moderating role of gender identification.

Kaiser CR, Spalding KE.
UIID-AD: 3878
2015;599-608. doi: 10.1002/ejsp.2113.

It is often expected that the first women to advance in male-dominated fields will promote other women who follow them. Two studies test the hypothesis that some women show this expected pattern of promoting women but that others show...

Cite
Kaiser CR, Spalding KE. Do women who succeed in male-dominated domains help other women? The moderating role of gender identification. 2015;599-608doi: 10.1002/ejsp.2113.
Kaiser, C. R., & Spalding, K. E. (2015). Do women who succeed in male-dominated domains help other women? The moderating role of gender identification. 599-608. https://doi.org/10.1002/ejsp.2113
Kaiser, C R, and Spalding, K E. "Do women who succeed in male-dominated domains help other women? The moderating role of gender identification." vol. (2015): 599-608. doi: https://doi.org/10.1002/ejsp.2113
Kaiser CR, Spalding KE. Do women who succeed in male-dominated domains help other women? The moderating role of gender identification. 2015;599-608. doi: 10.1002/ejsp.2113. UIID-AD: 3878.
Copy Download .nbib Format: NLM
Showing 145 to 155 of 155 entries